Revvity is the new name for the former PerkinElmer, Inc. Life Sciences and Diagnostics division, which was launched as a new company on the NYSE on May 16th, 2023.
Revvity is a visionary partner in developing technologies and solutions across disease pathways to help solve the world’s greatest health challenges.
Our purpose is to expand the boundaries of human potential through science.Together with our customers and partners, we embrace the impossible to bring this purpose to life.
We provide health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. With a robust global network and localized agility, we serve a diverse range of organizations from pharmaceutical and biotech, to clinical labs, academia, and governments.